Dear Reader ,
Here is your customized PHYSorg.com Newsletter for June 6, 2010:
Spotlight Stories Headlines
- A new approach to finding and removing defects in graphene (w/ Video)- 'Remote control' for cholesterol regulation discovered in brain
- BP says cap catching some 10,000 barrels a day
- Dell loses Taiwan consumer lawsuit: report
- European bison return to Spain: reports
- Australia launches privacy investigation of Google
- US rocket launch sparks Australia UFO frenzy
- Birds frozen in oil: image of a desperate summer
- Pfizer lung cancer drug promising in early tests
- iPad imitators hope to bite into Apple's lead
Space & Earth news
Canada cuts greenhouse gas emissions target for 2010-2012
The Canadian government quietly cut its greenhouse gas emissions target for 2010-2012 this week, unleashing a firestorm of criticism from the opposition on Friday.
Cyclone Phet kills 15 in Oman
Cyclone Phet killed 15 people and left two missing in Oman before barrelling towards Pakistan, a civil defence force official said on Saturday.
Obama vows help as BP sees oil spill progress
US President Barack Obama promised on Saturday to use "every resource" to help those affected by the Gulf of Mexico oil spill, as Americans awaited news of BP's latest containment effort.
US rocket launch sparks Australia UFO frenzy
A bright spiralling light, believed by astronomers to be a rocket launched from Cape Canaveral, was spotted in skies across Australia's east coast just before dawn Saturday, sparking a UFO frenzy.
BP says cap catching some 10,000 barrels a day
Engineers searched for ways to capture more oil flowing from a ruptured well in the Gulf of Mexico Sunday after energy giant BP said a cap was currently catching around 10,000 barrels a day.
Technology news
Calif. mom finds missing children using Facebook
(AP) -- A Southern California mother whose two children were reported missing 15 years ago has tracked them down in Florida using Facebook.
Foxconn to give Chinese workers another pay raise
(AP) -- Foxconn workers in China will get another pay raise in coming months, on top of an increase that just took effect in response to recent worker suicides, the company said Sunday.
Bangladesh lifts Facebook ban
(AP) -- Bangladesh has lifted a weeklong ban on the social networking website Facebook imposed for a page urging people to draw images of Islam's Prophet Muhammad, an official said Sunday.
Oracle cutting more Sun jobs
(AP) -- Oracle Corp. is cutting more jobs as part of its takeover of slumping computer-server maker Sun Microsystems.
Credit card fraudsters take aim at World Cup
Jean-Pierre arrived on his South African holiday, withdrew some money from a cash machine, and hours later received a call from his bank to say that 300 euros had suddenly been charged to him.
Global downturn a thing of the past for Asia's top IT show
If Asia's largest IT fair, the just-concluded Computex, is anything to go by, the high-tech industry is emerging rapidly from the global crisis: business was brisk during the five-day event in Taipei.
Australia launches privacy investigation of Google
(AP) -- Australia announced a police investigation Sunday into whether Google illegally collected private information from wireless networks, becoming at least the second country to probe the Internet giant's "Street View" mapping service.
Dell loses Taiwan consumer lawsuit: report
A group of Taiwanese consumers have won a lawsuit forcing US computer giant Dell to honour bargains the firm says it offered in error on the Internet, it was reported Sunday.
Medicine & Health news
Tongue measurements may help dentists determine oral appliance therapy success for sleep apnea
According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the ratio between tongue volume and bony enclosure size in patients with obstructive sleep apnea (OSA) may help dentists calculate oral appliance treatment success.
Sleep-disordered breathing is common but hard to detect in pediatric patients
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
Nasendoscopy proves useful in predicting treatment success in sleep apnea patients
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, nasendoscopy may help dentists predict oral appliance therapy success in sleep apnea patients. Nasendoscopy involves a flexible endoscope being inserted through the nasal cavity. The tip of the scope is placed at the level of the velopharynx and oro-/hypopharynx.
US dental schools leave graduates unprepared to screen for sleep disorders
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the majority of U.S. dental schools have not adequately prepared their graduates to screen for sleep disorders, which affect more than 70 million adults in the U.S.
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas MD Anderson Cancer Center.
Questionnaires help dentists screen for sleep-disordered breathing in children
According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, questionnaires can help dentists screen for sleep-disordered breathing (SDB) in a pediatric population. SDB includes obstructive sleep apnea (OSA), upper-airway resistance syndrome, and snoring.
Sleep apnea patients using oral appliance therapy show high efficacy and compliance
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, between 31 and 53 months after beginning oral appliance therapy, the sleep apnea treatment remained effective. Subjective daytime sleepiness, fatigue severity, and quality of life also remained improved.
Second-line CML drugs evoke faster, better front-line remissions
Two drugs approved for treatment of drug-resistant chronic myeloid leukemia provide patients with quicker, better responses as a first therapy than the existing front-line medication, according to two studies published online by the New England Journal of Medicine.
Combination treatment regimen not effective against advanced melanoma
The combination of two different chemotherapies and a previously approved treatment for kidney and liver cancers is not effective against advanced melanoma, according to results disclosed in an oral presentation today at the 46th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Drug boosts survival in major skin cancer study
(AP) -- Researchers have scored the first big win against melanoma, the deadliest form of skin cancer. An experimental drug significantly improved survival in a major study of people with very advanced disease.
Selenium shows no benefit in prevention of lung cancer
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
New treatment regimen shown effective against advanced ovarian cancer
Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.
'Remote control' for cholesterol regulation discovered in brain
Circulation of cholesterol is regulated in the brain by the hunger-signaling hormone ghrelin, researchers say. The finding points to a new potential target for the pharmacologic control of cholesterol levels.
Pfizer lung cancer drug promising in early tests
(AP) -- It's way too soon to declare success, but an experimental drug for lung cancer patients with a certain gene showed extraordinary promise in early testing, doctors reported at a cancer conference on Saturday.
Biology news
Birds frozen in oil: image of a desperate summer
(AP) -- They are the ghastly images of a summer fouled before it started. Squawking seagulls and majestic brown pelicans coated in oil. Click. Gunk dripping from their beaks. Click. Big eyes wide open. Click. Even the professionals want to turn away. They can't.
European bison return to Spain: reports
The nearly extinct European bison has been reintroduced after centuries in Spain with seven animals coming from a rare herd in Poland, Spanish media reported Saturday.
This email is a free service of PhysOrg.com
You received this email because you subscribed to our list.
If you no longer want to receive this email use the link below to unsubscribe.
http://www.physorg.com/profile/nwletter/
You are subscribed as mail@joashmabs.com
No comments:
Post a Comment